Singapore Intellectual Property Blog

The 17th General Assembly 64th and 65th Council Meetings of the Asian Patent Attorneys Association (APAA) will be held this year from 13 to 17 November 2015 in Okinawa, Japan.

IPOS has announced that a Singapore patent can be re-registered as a patent in Cambodia. It is therefore now possible to obtain a Cambodian patent on the basis of a patent that has already been granted in Singapore.

The process is straightforward and may be worth considering for applicants who have commercial interests in the Kingdom of Cambodia.

IPOS has issued Practice Direction No. 2 of 2015, the effect of which is to declare the following as excluded days:

The Singapore High Court recently considered the allowability of post-grant amendments in the judgement of Ship’s Equipment Centre Bremen GmbH v Fuji Trading (Singapore) Pte Ltd [2015] SGHC 159.

This case is a stark reminder that post-grant patent amendments in Singapore remain discretionary, in contrast to the changes to the UK Patents Law introduced by the Patents Act 2004 and in consideration of EPC 2000.

This blog post deals with the filing of sequence listings in Singapore patent applications which contain disclosures of nucleotide and amino acid sequences.

Unlike other jurisdictions, there are no provisions in Singapore legislation relating to sequence listings. How then does an applicant file a sequence listing for a biotech patent application in Singapore?